H.C. Wainwright raised the firm’s price target on BioLife Solutions (BLFS) to $32 from $30 and keeps a Buy rating on the shares following the Q2 beat.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLFS: